Citation Impact
Citing Papers
Suppression of Aging in Mice by the Hormone Klotho
2005 StandoutScience
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
2005 StandoutScience
Bone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
1987 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
A Global Study of Vitamin D Status and Parathyroid Function in Postmenopausal Women with Osteoporosis: Baseline Data from the Multiple Outcomes of Raloxifene Evaluation Clinical Trial
2001
Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine
1995 Standout
Endothelin-1 Is a Potent Regulator of Human Bone Cell Metabolism In Vitro
1997
Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hip in patients with established vertebral osteoporosis
1999
Genetic Factors in Bone Turnover*
1991
Bone Formation Rate in Older Normal Women: Concurrent Assessment with Bone Histomorphometry, Calcium Kinetics, and Biochemical Markers*
1988
Falls Relate to Vitamin D and Parathyroid Hormone in an Australian Nursing Home and Hostel
1999
Cortisol regulates the expression of Notch in osteoblasts
2002
Structural changes in aging bone: Osteopenia in the proximal femurs of female mice
1991
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 Standout
The effect of a short course of calcium and vitamin d on bone turnover in older women
1996
Role of Transforming Growth Factor β in Human Disease
2000 Standout
Frequency of adynamic bone disease and aluminium storage in Italian uraemic patients--retrospective analysis of 1429 iliac crest biopsies
1996
Concurrent Assays of Circulating Bone Gla-Protein and Bone Alkaline Phosphatase: Effects of Sex, Age, and Metabolic Bone Disease*
1988
Assessment in Medical Education
2007 Standout
Vascularized and functional human liver from an iPSC-derived organ bud transplant
2013 StandoutNature
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
2001
Osteocalcin: A non-invasive index of metabolic bone disease in patients treated by CAPD
1994
Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: Sequential triple biopsy studies with micro-computed tomography
2006
Premature ageing in mice expressing defective mitochondrial DNA polymerase
2004 StandoutNature
Intrinsic Material Properties of Trabecular Bone by Nanoindentation Testing of Biopsies Taken from Healthy Women Before and After Menopause
2012
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
Hypovitaminosis D in Medical Inpatients
1998
Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older
1997 Standout
Circulating biochemical markers of bone remodeling in uremic patients
1999
Association of klotho gene polymorphism with bone density and spondylosis of the lumbar spine in postmenopausal women
2002
Osteomyelitis
1997 Standout
Osteoblastic cells regulate the haematopoietic stem cell niche
2003 StandoutNature
Growth in infancy and bone mass in later life
1997
Coping with complexity: educating for capability
2001
Addressing the Musculoskeletal Components of Fracture Risk with Calcium and Vitamin D: A Review of the Evidence
2006
Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1–38) and salmon calcitonin in osteoporotic patients
1991
Vitamin D Deficiency
2007 Standout
Vitamin D fortification in the United States and Canada: current status and data needs
2004
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
2008
AID Is Required for c-myc/IgH Chromosome Translocations In Vivo
2004 StandoutNobel
Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial.
1998
Effects of extracellular matrix viscoelasticity on cellular behaviour
2020 StandoutNature
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Intervention thresholds for osteoporosis
2002
Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients
2003
Prediction of bone density from vitamin D receptor alleles
1994 StandoutNature
Occult Vitamin D Deficiency in Postmenopausal US Women With Acute Hip Fracture
1999
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
1997 StandoutNature
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
1999
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 Standout
Prevention of Estrogen Deficiency–Related Bone Loss With Human Parathyroid Hormone–(1-34)
1998
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Human Growth Hormone and Human Aging
1993
Wnt/β-Catenin Signaling and Disease
2012 Standout
The epidemiology of quantitative ultrasound: A review of the relationships with bone mass, osteoporosis and fracture risk
1997
Autophagy in the Pathogenesis of Disease
2008 Standout
Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial
2008
Bone Marrow, Cytokines, and Bone Remodeling — Emerging Insights into the Pathophysiology of Osteoporosis
1995
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
1999 StandoutNature
Fracture Prevention With Vitamin D Supplementation
2005
Mechanisms of Glucocorticoid Action in Bone
2002
Cost-Effectiveness of Preventing Hip Fracture in the General Female Population
2001
The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis
2003
Importance of Albumin, 25(OH)-Vitamin D and IGFBP-3 as Risk Factors in Elderly Women and Men with Hip Fracture
1997
The Role of the Wnt-Signaling Antagonist DKK1 in the Development of Osteolytic Lesions in Multiple Myeloma
2003
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Osteoclast differentiation and activation
2003 StandoutNature
Risk factors for hip fracture in a high incidence area: A case-control study from Oslo, Norway
1995
Assessment of fracture risk
2004
Vitamin D3and Calcium to Prevent Hip Fractures in Elderly Women
1992 Standout
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone
2014 StandoutNature
Excessive bone resorption in human plasmacytomas: direct induction by tumour cells in vivo
1995
Relationship between intact 1–84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity
1995
Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: A randomized, placebo-controlled trial
1996
Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study
1996
Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption
1992
Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women
2000
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Osteoporosis in hemodialysis patients revisited by bone histomorphometry: A new insight into an old problem
2006
The pathogenesis and treatment of hip fractures
1991
Osteoclasts are required for bone tumors to grow and destroy bone
1998
No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients
1997
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Anabolic Actions of Parathyroid Hormone on Bone*
1993
Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis
1996
Production and Actions of Estrogens
2002 Standout
Mechanisms of Bone Metastasis
2004 Standout
The vitamin D questions: How much do you need and how should you get it?
2006
Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain
2005 StandoutNobel
A meta-analysis of milk intake and fracture risk: low utility for case finding
2004
Prevalence of Vitamin D Insufficiency in an Adult Normal Population
1997 Standout
Comparison of the bone mineral content of the lower limbs in men with ischaemic atherosclerotic disease
1994
Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with Osteoporosis
1990 Standout
Bisphosphonates
1991
Osteomalacia and osteoporosis in femoral neck fracture
1990
Frailty in elderly people
2013 Standout
The Histomorphometry of Bone in Primary Hyperparathyroidism: Preservation of Cancellous Bone Structure*
1990
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis
2009
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study
2000
Neoplastic development in plasma cells
2003
Effect of In Utero and Early-Life Conditions on Adult Health and Disease
2008 Standout
Leptin Inhibits Bone Formation through a Hypothalamic Relay
2000 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
How About Vitamin D Receptor Polymorphisms?
1998
Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
2008
Current strategies for integrative cartilage repair
2016
Calciotropic Hormones and Bone Markers in the Elderly
1998
Recombinant Human Parathyroid Hormone (1–34) [Teriparatide] Improves Both Cortical and Cancellous Bone Structure
2003
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001
Intermittently Administered Human Parathyroid Hormone(1–34) Treatment Increases Intracortical Bone Turnover and Porosity Without Reducing Bone Strength in the Humerus of Ovariectomized Cynomolgus Monkeys
2001
Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: A comparative histomorphometric study
1987
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
Environmental factors that influence the cutaneous production of vitamin D
1995
Mechanisms of Bone Lesions in Multiple Myeloma
1992
Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
1987 Standout
Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. EPIDOS Study Group.
1996
Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee
2012 Standout
Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial
2005
Vitamin D Repletion in Patients with Primary Hyperparathyroidism and Coexistent Vitamin D Insufficiency
2005
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001 Standout
Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
1996
Calcium and vitamin D supplements: effects on calcium metabolism in elderly people
1987
Klotho Gene Polymorphisms Associated With Bone Density of Aged Postmenopausal Women
2002
Biochemical Markers of Bone Turnover, Endogenous Hormones and the Risk of Fractures in Postmenopausal Women: The OFELY Study
2000
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay
1992
Catabolic Effects of Continuous Human PTH (1–38) in Vivo Is Associated with Sustained Stimulation of RANKL and Inhibition of Osteoprotegerin and Gene-Associated Bone Formation
2001
Appendicular Bone Density and Age Predict Hip Fracture in Women
1990
Contribution of Genetic Factors to the Pathogenesis of Paget's Disease of Bone and Related Disorders
2006
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Weight-Bearing Exercise Training and Lumbar Bone Mineral Content in Postmenopausal Women
1988
The Role of Vitamin D in Cancer Prevention
2005 Standout
Hypovitaminosis D in Healthy Schoolchildren
2001
In Vivo Magnetic Resonance Detects Rapid Remodeling Changes in the Topology of the Trabecular Bone Network After Menopause and the Protective Effect of Estradiol
2008
Effects of Ethnicity and Age or Menopause on Osteoblast Function, Bone Mineralization, and Osteoid Accumulation in Iliac Bone
1997
Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study
1996
Association of a Polymorphism of the Transforming Growth Factor-β1 Gene with Genetic Susceptibility to Osteoporosis in Postmenopausal Japanese Women
1998
Predictive Value of BMD for Hip and Other Fractures
2005
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
1997 StandoutScience
Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma with special reference to osteomalacia
1983
Vitamin D and Calcium Supplementation Prevents Osteoporotic Fractures in Elderly Community Dwelling Residents: A Pragmatic Population-Based 3-Year Intervention Study
2004
Relations between histologic indices of bone formation: Implications for the pathogenesis of spinal osteoporosis
1995
Risk Factors for Hip Fracture in White Women
1995 Standout
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients
1996
Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D
1995
Quantitative Ultrasound Techniques for the Assessment of Osteoporosis: Expert Agreement on Current Status
1997
Skeletal disease in primary hyperparathyroidism
1989
Bone destruction and hypercalcemia in plasma cell myeloma.
1986
Reconstruction of human elastic cartilage by a CD44 + CD90 + stem cell in the ear perichondrium
2011
Bisphosphonates: Mechanisms of Action
1998
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout
The proportion of trabecular bone in human vertebrae
1987
Works of M. Arlot being referenced
Impaired osteoblast function in osteoporosis: comparison between calcium balance and dynamic histomorphometry.
1984
Trabecular bone microarchitecture after alendronate treatment of osteoporotic women
2005
Skeletal Blood Flow, Iliac Histomorphometry, and Strontium Kinetics in Osteoporosis: A Relationship Between Blood Flow and Corrected Apposition Rate
1988
Influence of anthropometric parameters on ultrasound measurements of os calcis
1995
Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women
1994
Can we stop bone loss and prevent hip fractures in the elderly?
1994
The relationship between serum vitamin D concentrations andin vivo tetracycline labeling of osteoid in crush fracture osteoporosis
1991
hPTH 1–34 treatment of osteoporosis with added hormone replacement therapy: Biochemical, kinetic and histological responses
1991
Treatment of osteoporosis with parathyroid peptide (hPTH 1–34) and oestrogen: increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone
1992
Calcium–vitamin D3 supplementation is cost-effective in hip fractures prevention
2003
Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis.
1997
The anabolic effect of human PTH (1–34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate—is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system?
1995
Human parathyroid peptide treatment of vertebral osteoporosis
1993
Trabecular and endocortical bone remodeling in postmenopausal osteoporosis: Comparison with normal postmenopausal women
1990
Intersample variation in bone histomorphometry: Comparison between parameter values measured on two contiguous transiliac bone biopsies
1985
Evidence for a toxic effect of aluminum on osteoblasts: A histomorphometric study in hemodialysis patients with aplastic bone disease
1988
Do ultrasound measurements on the os calcis reflect more the bone microarchitecture than the bone mass?: A two-dimensional histomorphometric study
1995
Effects of Parathyroid Hormone on Remodeling of Iliac Trabecular Bone Packets in Patients with Primary Hyperparathyroidism
1982
Heterogeneity of Fracture Syndromes in Postmenopausal Women
1986
Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin
1987
Active Bone Turnover of the Cortico-Endosteal Envelope in Postmenopausal Osteoporosis*
1987
Serum bone Gla-protein compared to bone histomorphometry in endocrine diseases
1985
Histomorphometric and μCT Analysis of Bone Biopsies From Postmenopausal Osteoporotic Women Treated With Strontium Ranelate
2007
Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: The OFELY study
1996
Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: The influence of human parathyroid fragment (hPTH 1-34) therapy
1981
Vitamin D3 and Calcium to Prevent Hip Fractures in Elderly Women
1993
Quantitative histology of myeloma‐induced bone changes
1982
Intravenous disodium etidronate therapy in Paget's disease of bone and hypercalcemia of malignancy: Effects on biochemical parameters and bone histomorphometry
1987
Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women
1994
Differential Effects of Teriparatide and Alendronate on Bone Remodeling in Postmenopausal Women Assessed by Histomorphometric Parameters
2005
Serum Bone Gla-Protein in Renal Osteodystrophy:Comparison with Bone Histomorphometry*
1986
Apparent Pre- and Postmenopausal Bone Loss Evaluated by DXA at Different Skeletal Sites in Women: The OFELY Cohort
1997
Comparison of Trabecular Bone Microarchitecture and Remodeling in Glucocorticoid-Induced and Postmenopausal Osteoporosis
2001
Periodic courses of human 1–34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosis
1987
Bone histomorphometry in pacet's disease quantitative and dynamic analysis of pagetic and nonpagetic bone tissue
1980
Serum osteocalcin is increased in patients with osteomalacia: correlations with biochemical and histomorphometric findings.
1992
Heterogeneity of Fracture Syndromes in Postmenopausal Women*
1985
The Cell Density of Human Femoral Head Cartilage
1976